AnalystsRaju Prasad
Raju Prasad's Stock Forecasts

Sectors:

Healthcare

Industries:

Biotechnology

Analyst Ranking

Bottom 15%

#3917 out of 4566 analysts

Average Return

-10.22%

Win Rate

30%3 out of 10

Risk vs Reward

Poor

Good

Raju Prasad's 5 best and worst ratings

Name / Ticker	Gain/Loss	Entry Price	Exit Price	Period	Rating
Global Blood Therapeutics IncGBT	+131.23%	$29.62	$68.49	2021-12-07 - 2022-10-04	Buy
Avexis IncAVXS	+127.69%	$95.67	$217.83	2017-08-23 - 2018-05-15	Buy
Audentes Therapeutics IncBOLD1	+12.63%	$25.10	$28.27	2017-10-17 - 2018-10-17	Buy

Raju Prasad Analyst Color

Get additional color on Raju Prasad's coverage of popular stocks

Raju Prasad's Stock Coverage

Name / Ticker	No. Ratings	Rating	Price Target	Upside/Downside	Action	Date
Intellia Therapeutics IncNTLA	1	Buy	N/A	N/A	Initiates Coverage On	2 years ago
Logicbio Therapeutics IncLOGC	1	Hold	N/A	N/A	Downgrades	2 years ago
Global Blood Therapeutics IncGBT	2	Buy	N/A	N/A	Upgrades	2 years ago
Verve Therapeutics IncVERV	1	Buy	$92.00	N/A	Initiates Coverage On	3 years ago
Cartesian Therapeutics IncRNAC	2	Buy	N/A	N/A	Upgrades	3 years ago
Taysha Gene Therapies IncTSHA	1	Buy	$46.00	N/A	Initiates Coverage On	3 years ago
Generation Bio CoGBIO	1	Buy	$45.00	N/A	Initiates Coverage On	3 years ago
Crispr Therapeutics AgCRSP	1	Hold	N/A	N/A	Initiates Coverage On	5 years ago
Audentes Therapeutics IncBOLD1	2	Hold	N/A	N/A	Downgrades	5 years ago
Ptc Therapeutics IncPTCT	2	Buy	N/A	N/A	Upgrades	6 years ago
Avexis IncAVXS	1	Buy	N/A	N/A	Initiates Coverage On	7 years ago

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.